Sonendo's GentleWave System: Innovative Dental Solution for Root Canal Therapy

Sonendo's GentleWave System: Revolutionizing Root Canal Treatment with Innovative Technology

Sonendo's GentleWave System is a groundbreaking dental technology designed to treat tooth decay by cleaning and disinfecting the microscopic spaces within teeth, all while preserving the tooth structure. This innovative system employs a unique mechanism of action that combines procedure fluid optimization, broad-spectrum acoustic energy, and advanced fluid dynamics. This combination allows for effective debridement and disinfection of the complex root canal system in a minimally invasive manner.

Benefits of the GentleWave System

The clinical advantages of the GentleWave System over traditional root canal therapies are significant. It offers superior cleaning capabilities that are not dependent on the complexity of the root canal or the anatomy of the tooth. Patients experience high and rapid healing rates with minimal to no post-operative pain. Additionally, the GentleWave System enhances the workflow and economics of dental practices, making it a valuable tool for modern dentistry.

For more information about Sonendo and the GentleWave System, please visit www.sonendo.com. To find a GentleWave doctor near you, visit www.gentlewave.com.

Forward-Looking Statements

This press release contains forward-looking statements regarding Sonendo’s future financial performance, including full-year 2024 revenue guidance and potential acquisition of Biolase assets. These statements are based on current expectations and assumptions and are subject to risks and uncertainties that may cause actual results to differ materially. Factors influencing these outcomes include market conditions, regulatory approvals, and integration of acquired assets.

Sonendo advises caution in placing undue reliance on these statements, as they are not guarantees of future performance. The company disclaims any obligation to update forward-looking statements as new information becomes available.

Preliminary Financial Information

The financial information presented is based on preliminary, unaudited results for the quarter ending September 30, 2024. These results are subject to adjustments during the finalization of quarter-end procedures. As such, they should be considered forward-looking and may change upon further review.

For detailed risk factors and additional information, please refer to Sonendo’s filings with the Securities and Exchange Commission at www.sec.gov.